Science, public health, and public awareness: Lessons from the women's health initiative

Annals of Internal Medicine

Volumn 138, Issue 4, 2003, Pages 352-353

  Dentzer, Susan ^a,b  

^a The News Hour with Jim Lehrer   (United States)

^b NewsHour with Jim Lehrer   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AWARENESS; HEALTH CARE ORGANIZATION; HEALTH PROGRAM; HEALTH PROMOTION; HORMONE SUBSTITUTION; HUMAN; MASS MEDIUM; PATIENT ATTITUDE; PRIORITY JOURNAL; REVIEW;

EID: 0037452520     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-138-4-200302180-00018     Document Type: Review

References (4)

1. Kirschstein R. Menopausal hormone therapy: summary of a scientific workshop. Ann Intern Med. 2003;138:361-4.
2. Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, et al. Risks and benefits of estrogen plus progestin in healthy post-menopausal women: principal results from the Women's Health initiative randomized controlled trial. JAMA. 2002;288:321-33. [PMID: 12117397]
3. Hulley S, Grady D, Bush T, Furberg C, Herrington D, Riggs B, et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group. JAMA. 1998;280:605-13. [PMID: 9718051]
4. Partnership for Prevention. Women, Hormone Replacement Therapy and Disease Prevention. Topline data. Accessed at www.prevent.org/surveyresults.htm on 1 January 2003.